• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量和定性血管造影病变形态及临床特征在预测原位冠状动脉球囊血管成形术期间及术后主要不良心脏事件中的作用。CARPORT和MERCATOR研究组。

Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. CARPORT and MERCATOR Study Groups.

作者信息

Hermans W R, Foley D P, Rensing B J, Rutsch W, Heyndrickx G R, Danchin N, Mast G, Hanet C, Lablanche J M, Rafflenbeul W

机构信息

Thoraxcenter, Rotterdam, The Netherlands.

出版信息

Am J Cardiol. 1993 Jul 1;72(1):14-20. doi: 10.1016/0002-9149(93)90211-t.

DOI:10.1016/0002-9149(93)90211-t
PMID:8517422
Abstract

Major, adverse cardiac events (death, myocardial infarction, bypass surgery and reintervention) occur in 4 to 7% of all patients undergoing coronary balloon angioplasty. Prospectively collected clinical data, and angiographic quantitative and qualitative lesion morphologic assessment and procedural factors were examined to determine whether the occurrence of these events could be predicted. Of 1,442 patients undergoing balloon angioplasty for native primary coronary disease in 2 European multicenter trials, 69 had major, adverse cardiac procedural or in-hospital complications after > or = 1 balloon inflation and were randomly matched with patients who completed an uncomplicated in-hospital course after successful angioplasty. No quantitative angiographic variable was associated with major adverse cardiac events in univariate and multivariate analyses. Univariate analysis showed that major adverse cardiac events were associated with the following preprocedural variables: (1) unstable angina (odds ratio [OR] 3.11; p < 0.0001), (2) type C lesion (OR 2.53; p < 0.004), (3) lesion location at a bend > 45 degrees (OR 2.34; p < 0.004), and (4) stenosis located in the middle segment of the artery dilated (OR 1.88; p < 0.03); and with the following postprocedural variable: angiographically visible dissection (OR 5.39; p < 0.0001). Multivariate logistic analysis was performed to identify variables independently correlated with the occurrence of major adverse cardiac events. The preprocedural multivariate model entered unstable angina (OR 3.77; p < 0.0003), lesions located at a bend > 45 degrees (OR 2.87; p < 0.0005), and stenosis located in the middle portion of the artery dilated (OR 1.95; p < 0.04).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在所有接受冠状动脉球囊血管成形术的患者中,主要不良心脏事件(死亡、心肌梗死、搭桥手术和再次干预)的发生率为4%至7%。对前瞻性收集的临床数据、血管造影定量和定性病变形态学评估以及手术因素进行了研究,以确定这些事件的发生是否可以预测。在两项欧洲多中心试验中,1442例因原发性冠状动脉疾病接受球囊血管成形术的患者中,69例在≥1次球囊扩张后出现主要不良心脏手术或住院并发症,并与血管成形术成功后完成无并发症住院过程的患者进行随机匹配。在单变量和多变量分析中,没有定量血管造影变量与主要不良心脏事件相关。单变量分析显示,主要不良心脏事件与以下术前变量相关:(1)不稳定型心绞痛(优势比[OR]3.11;p<0.0001),(2)C型病变(OR 2.53;p<0.004),(3)病变位于>45度的弯曲处(OR 2.34;p<0.004),以及(4)狭窄位于扩张动脉的中段(OR 1.88;p<0.03);并与以下术后变量相关:血管造影可见的夹层(OR 5.39;p<0.0001)。进行多变量逻辑分析以确定与主要不良心脏事件发生独立相关的变量。术前多变量模型纳入了不稳定型心绞痛(OR 3.77;p<0.0003)、位于>45度弯曲处的病变(OR 2.87;p<0.0005)以及位于扩张动脉中段的狭窄(OR 1.95;p<0.04)。(摘要截短于250字)

相似文献

1
Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. CARPORT and MERCATOR Study Groups.定量和定性血管造影病变形态及临床特征在预测原位冠状动脉球囊血管成形术期间及术后主要不良心脏事件中的作用。CARPORT和MERCATOR研究组。
Am J Cardiol. 1993 Jul 1;72(1):14-20. doi: 10.1016/0002-9149(93)90211-t.
2
Relation of clinical presentation, stenosis morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty.临床表现、狭窄形态以及术者技术与旋磨术及旋磨术辅助血管成形术手术结果的关系。
Circulation. 1994 Feb;89(2):882-92. doi: 10.1161/01.cir.89.2.882.
3
Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).冠状动脉球囊血管成形术成功后进行治疗性剥离:对693例患者的再狭窄或临床结局无影响。MERCATOR研究组(血管成形术后使用西拉普利预防经腔冠状动脉阻塞和再狭窄的多中心欧洲研究试验)。
J Am Coll Cardiol. 1992 Oct;20(4):767-80. doi: 10.1016/0735-1097(92)90171-i.
4
Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry.性别对冠状动脉介入治疗新方法(NACI)注册研究中的院内临床及血管造影结果以及一年随访的影响。
Am J Cardiol. 1997 Nov 20;80(10A):26K-39K. doi: 10.1016/s0002-9149(97)00762-5.
5
Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.经皮冠状动脉介入治疗器械再狭窄倾向的差异。球囊血管成形术、定向旋切术、支架植入术和准分子激光血管成形术的定量血管造影比较。CARPORT、MERCATOR、MARCATOR、PARK和BENESTENT试验组。
Eur Heart J. 1995 Oct;16(10):1331-46. doi: 10.1093/oxfordjournals.eurheartj.a060740.
6
Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.
Circulation. 1990 Oct;82(4):1193-202. doi: 10.1161/01.cir.82.4.1193.
7
Local lesion-related factors and restenosis after coronary angioplasty. Evidence from a quantitative angiographic study in patients with unstable angina undergoing double-vessel angioplasty.
Circulation. 1995 Feb 15;91(4):968-72. doi: 10.1161/01.cir.91.4.968.
8
Frequency and predictors of major in-hospital ischemic complications after planned and unplanned new-device angioplasty from the New Approaches to Coronary Intervention (NACI) registry.来自冠状动脉介入新方法(NACI)注册研究的计划内和计划外新器械血管成形术后主要院内缺血性并发症的发生率及预测因素。
Am J Cardiol. 1997 Nov 20;80(10A):40K-49K. doi: 10.1016/s0002-9149(97)00763-7.
9
Coronary angioplasty, bypass surgery, and retransplantation in cardiac transplant patients with graft coronary disease.患有移植物冠状动脉疾病的心脏移植患者的冠状动脉血管成形术、搭桥手术和再次移植。
Thorac Cardiovasc Surg. 1998 Oct;46(5):268-74. doi: 10.1055/s-2007-1010237.
10
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing.
Eur Heart J. 2003 Mar;24(6):541-51. doi: 10.1016/s0195-668x(02)00422-0.

引用本文的文献

1
Pragmatic Evaluation of an Improvement Program for People Living With Modifiable High-Risk COPD Versus Usual Care: Protocols for the Cluster Randomized PREVAIL Trial.针对可改变的高危慢性阻塞性肺疾病患者的改善计划与常规护理的实用性评估:整群随机PREVAIL试验方案
Chronic Obstr Pulm Dis. 2025 May 27;12(3):223-239. doi: 10.15326/jcopdf.2024.0564.
2
Effect of Intravascular Ultrasonography (IVUS) Imaging on Stent Optimization in Patients Achieving Optimal Results After Angiographic-Guided Stent Implantation: A Non-randomized Interventional Study.血管内超声(IVUS)成像对血管造影引导下支架植入术后获得最佳结果的患者支架优化的影响:一项非随机干预性研究。
Cureus. 2025 Jan 15;17(1):e77458. doi: 10.7759/cureus.77458. eCollection 2025 Jan.
3
Using the Cardiac-Electrophysiological Balance Index to Predict Arrhythmia Risk After Colonoscopy.
使用心脏电生理平衡指数预测结肠镜检查后的心律失常风险。
Medicina (Kaunas). 2024 Dec 26;61(1):13. doi: 10.3390/medicina61010013.
4
Volumetric Stent Expansion Index to Assess Tapering Lesions Using Intravascular Ultrasound and Its Clinical Outcomes.使用血管内超声评估锥形病变的容积支架扩张指数及其临床结果
Rev Cardiovasc Med. 2024 Feb 5;25(2):57. doi: 10.31083/j.rcm2502057. eCollection 2024 Feb.
5
Calcified Nodules in Non-Culprit Lesions with Acute Coronary Syndrome Patients.急性冠状动脉综合征患者非罪犯病变中的钙化结节
Rev Cardiovasc Med. 2024 Apr 7;25(4):136. doi: 10.31083/j.rcm2504136. eCollection 2024 Apr.
6
Clinical Implications of Acute Stent Mal-Apposition in the Left Main Coronary Artery.左主干冠状动脉急性支架贴壁不良的临床意义
Rev Cardiovasc Med. 2024 May 29;25(6):196. doi: 10.31083/j.rcm2506196. eCollection 2024 Jun.
7
Cardiovascular Events and Mortality in Patients on Hemodialysis: The Prognostic Value of the CHADS-VASc Score.血液透析患者的心血管事件和死亡率:CHADS-VASc 评分的预后价值。
Medicina (Kaunas). 2024 Jan 12;60(1):144. doi: 10.3390/medicina60010144.
8
Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome.新型生物标志物及其在急性冠状动脉综合征诊断和预后中的作用
Life (Basel). 2023 Sep 29;13(10):1992. doi: 10.3390/life13101992.
9
Data Pseudonymization in a Range That Does Not Affect Data Quality: Correlation with the Degree of Participation of Clinicians.数据在不影响数据质量的范围内进行伪匿名化:与临床医生参与程度的相关性。
J Korean Med Sci. 2021 Nov 15;36(44):e299. doi: 10.3346/jkms.2021.36.e299.
10
NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study.接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的N末端B型利钠肽原与主要不良心血管事件:一项前瞻性队列研究。
Cardiol Res Pract. 2021 Nov 2;2021:9943668. doi: 10.1155/2021/9943668. eCollection 2021.